msfindia.in
Donation FAQ | MSF India
http://www.msfindia.in/donation-faq
Skip to main content area. Independent Medical Humanitarian Action. Nepal earthquake emergency response. Work in India (Projects). Work in India (Office). Letters from the Field. Month In Focus - July 2016. Month In Focus - May 2016. Month In Focus - January 2016. Month In Focus - June 2016. Month in Focus - February 2016. Month in Focus April 2016. Month in Focus - December 2015. Month in Focus - November 2015. Month in Focus - October 2015. Month in Focus - September 2015. Month in Focus August 2015.
msfindia.in
Walking that extra mile | MSF India
http://www.msfindia.in/walking-extra-mile
Skip to main content area. Independent Medical Humanitarian Action. Nepal earthquake emergency response. Work in India (Projects). Work in India (Office). Letters from the Field. Month In Focus - July 2016. Month In Focus - May 2016. Month In Focus - January 2016. Month In Focus - June 2016. Month in Focus - February 2016. Month in Focus April 2016. Month in Focus - December 2015. Month in Focus - November 2015. Month in Focus - October 2015. Month in Focus - September 2015. Month in Focus August 2015.
msfindia.in
Support us | MSF India
http://www.msfindia.in/support-us
Skip to main content area. Independent Medical Humanitarian Action. Nepal earthquake emergency response. Work in India (Projects). Work in India (Office). Letters from the Field. Month In Focus - July 2016. Month In Focus - May 2016. Month In Focus - January 2016. Month In Focus - June 2016. Month in Focus - February 2016. Month in Focus April 2016. Month in Focus - December 2015. Month in Focus - November 2015. Month in Focus - October 2015. Month in Focus - September 2015. Month in Focus August 2015.
patentoppositions.org
Patent Opposition Database
http://www.patentoppositions.org/en/home
Join our community to challenge unfair drug patents. March 2016: The Patent Opposition Database has just been upgraded with new features to promote user collaboration and to make our content more easily accessible. New features include: document annotations, calls for help, advanced search features, exportable search results and RSS feeds, subscription to alerts. Search our database of international drug patent oppositions. Example searches: India, India 2004, atazanavir, TDF, AIDS, US 5599670, etc.
patentoppositions.org
Patent Opposition Database: Case Study
http://www.patentoppositions.org/en/case_studies/4f106d0504a7f92f5b000003
Join our community to challenge unfair drug patents. Success Story: The Case Of Tdf In Brazil. Success Story: The Case of TDF in Brazil. In Brazil, the drug tenofovir disoproxil fumarate (TDF). Is widely used as part of first and second-line HIV treatment regimens. The medicine was incorporated into the country’s treatment guidelines in 2003 but not without numerous disputes over price. The successful pre-grant opposition is emblematic. It was the first time a patent related to an antiretroviral (ARV...
patentoppositions.org
Patent Opposition Database: Drugs: Sofosbuvir (GS7977)
http://www.patentoppositions.org/en/drugs/51dfee9097961f0002000020
Join our community to challenge unfair drug patents. Brazil, India, Korea, Republic of, Russian Federation, and United States. This drug is missing the following documents, can you help us by contributing something. Information related to patents filed both at the local and the international levels. The table includes patent applications related to this medicine as filed in different countries. Korea, Republic of. Help us by contributing missing data: Contribute. Uarr; Back to Top. Sankalp Rehabilitation...
patentoppositions.org
Patent Opposition Database
http://www.patentoppositions.org/en/contribute
Join our community to challenge unfair drug patents. When contesting a patent to prevent an unwarranted monopoly on a medicine, it is critical to include as much information and supporting documents as possible to help build an argument against a patent. For this database to become as effective a tool against patent system abuse as possible, contributions from people with experience in filing patent oppositions are crucial. Contributors do not have to identify themselves to upload information or documents.
SOCIAL ENGAGEMENT